Erpeng Yang
Xiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Activated PRKCD-mediated neutrophil extracellular traps pathway may be the prothrombotic mechanism of neutrophils in polycythemia vera patients based on clinical retrospective analysis and bioinformatics study.
Journal: International immunopharmacology
Published: September 07, 2023
Proteomic-Based Platelet Activation-Associated Protein SELP May Be a Novel Biomarker for Coagulation and Prognostic in Essential Thrombocythemia.
Journal: Journal of clinical medicine
Published: November 18, 2022
Coagulation status and determinants of possible aspirin resistance in patients with essential thrombocythemia.
Journal: Frontiers in medicine
Published: November 07, 2022
TET2 Mutation May Be More Valuable in Predicting Thrombosis in ET Patients Compared to PV Patients: A Preliminary Report.
Journal: Journal of clinical medicine
Published: October 08, 2022
Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera.
Journal: Cancers
Published: August 28, 2022
Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis.
Journal: Annals of hematology
Published: April 17, 2021
The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 12, 2021
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis.
Journal: Annals of hematology
Published: November 22, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026